Effect of cysteine ethylester hydrochloride (CystaninR) on host defense mechanisms. (IV). Potentiating effects on the function of peritoneal or spleen macrophages.
スポンサーリンク
概要
- 論文の詳細を見る
L-Cysteine ethylester hydrochloride (ethylcysteine; 30 mg/kg, p.o.) increased the number of la-positive cells (antigen presenting cells) in spleen adherent cells (SAC) and that of Lyt 1.2-positive cells (helper T cells), but not that of Lyt 2.2-positive cells (suppressor T cells) of C57BL/6 mice immunized with sheep red blood cells. The production of hemolytic plaque forming cells (HPFC) in spleens of syngeneic recipient mice was enhanced by the transfer of SAC or spleen lymphocytes of the donor mice pretreated with ethylcysteine. This drug augmented phagocytosis of yeast particles by peritoneal macrophages of ICR mice at concentrations of 1-100 μM. In ex vivo experiments, this drug (30 mg/kg, p.o.) augmented the phagocytosis of yeast particles by mouse macrophages and showed a tendency to increase the macrophage number in the peritoneal cavity. Ethylcysteine (30 mg/kg, p.o.) significantly accelerated the decrease of viable <I>E. coli</I> number in the liver of normal mice 2 and 48 hr after challenge. Furthermore, this drug at the same dose restored the suppression of the decrease of <I>E. coli</I> number in the blood and liver of mice treated with cyclophosphamide (200 mg/kg, i.p.). These results suggest that ethylcysteine augments the functions of macrophages in vitro and ex vivo, and these enhancing effects may lead to the enhancement of host resistance to infections in compromised hosts.
- 公益社団法人 日本薬理学会の論文
著者
-
Hisadome Masao
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
Terasawa Michio
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd
-
Ikegami Kiyoteru
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
KIMURA Yuka
Research Laboratories, Yoshitomi Pharmaceutical Industries, Ltd.
関連論文
- Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori-infected Mongolian gerbils
- Suppressive Effects of Y-24180, a Long-Acting Antagonist for Platelet-Activating Factor, on Allergic Pulmonary Eosinophilia in Mice
- IMMUNOPHARMACOLOGICAL PROPERTIES OF NEW ANTIALLERGIC AGENT Y-12,141
- Novel Renin Inhibitors Containing (2S, 3S, 5S)-2-Amino-1-cyclohexyl-6-methyl-3,5-heptanediol Fragment as a Transition-state Mimic at the P1-P1' Cleavage Site
- Effect of Y-24180, a Platelet-Activating Factor-Receptor Antagonist, on the Antigen-Induced Airway Microvascular Leakage in Guinea Pigs
- EFFECTS OF 2-{4-(2-IMIDAZO[1, 2-a]PYRIDYL)PHENYL} PROPIONIC ACID (Y-9213) ON IN VIVO RELEASE OF LYSOSOMAL ENZYMES FROM RAT POLYMORPHONUCLEAR LEUKOCYTES DURING PHAGOCYTOSIS OF PARTICLES
- EFFECTS OF 2-{4-(2-IMIDAZO[1, 2-a]PYRIDYL)PHENYL} PROPIONIC ACID (Y-9213) AND ANTI-INFLAMMATORY DRUGS ON ERYTHROCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND LYSOSOMES IN VITRO
- ANTI-ANAPHYLACTIC ACTIVITIES OF A NEW BENZOPYRANOPYRIDINE DERIVATIVE Y-12, 141 IN RATS AND GUINEA PIGS
- TRAXANOX AUGMENTS IMMUNE RESPONSE TO LIPOPOLYSACCHARIDE IN INBRED MICE: ROLE OF MACROPHAGES
- Stimulation of phagocytic activity of leukocytes and macrophages by traxanox sodium in mice and rats.
- Effect of cysteine ethylester hydrochloride (CystaninR) on host defense mechanisms. (IV). Potentiating effects on the function of peritoneal or spleen macrophages.
- An antagonistic activity of etizolam on platelet-activating factor(PAF). In vitro effects on platelet aggregation and PAF receptor binding.
- Effect of etizolam (Depas) on production of superoxide anion by platelet-activating factor and N-formyl-methionyl-leucyl-phenylalanine-stimulated guinea pig polymorphonuclear leukocytes.
- Effect of cysteine ethylester hydrochloride (Cystanin) on host defense mechanisms (V): Potentiation of nitroblue tetrazolium reduction and chemiluminescence in macrophages or leukocytes of mice or rats.